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The prevalence of tuberculin skin test positivity and the effect of
BCG vaccinations on tuberculin induration size in the eastern
Mediterranean region of Turkey
Ferda KAZANCI1, Ekrem GÜLER1, Canan EREN DAĞLI2, Mesut GARİPARDIÇ1, Mehmet DAVUTOĞLU1,
Esen İSPİROĞLU1, Hasan Çetin EKERBİÇER3, Hamza KARABİBER1

Aim: To evaluate the prevalence of tuberculin skin test (TST) positivity in Kahramanmaraş and interpret the size of
purified protein derivative (PPD) induration with respect to the number of Bacillus Calmette-Guerin (BCG) scars and
other factors.
Materials and methods: A total of 2979 school children between the ages of 7 and 17 years were evaluated. On the basis
of socioeconomic levels, 11 schools were selected and categorized into 3 subgroups: schools in the suburbs of the city
(Group 1), schools in the city center (Group 2), and private schools (Group 3). Children were injected with 5 TU/0.1
mL of PPD and the sizes of induration were measured after 72 h. The number of BCG scars and the sizes of induration
were recorded for each pupil.
Results: The TST was positive in 6.3% of the nonvaccinated students and in 7.5% of the vaccinated students (P > 0.05).
The number of BCG vaccination scars was 0 in 174 children (5.8%), 1 in 1232 children (41.4%), 2 in 1516 children
(50.9%), 3 in 54 children (1.8%), and 4 in 3 children (0.1%). The mean diameter of the size of the PPD induration for 0,
1, 2, 3, and 4 BCG vaccinations was 2.50 ± 4.05 mm, 5.60 ± 5.11 mm, 8.49 ± 5.09 mm, 8.46 ± 4.38 mm, and 7.66 ± 6.80
mm, respectively. The size of the induration was greatest in students vaccinated twice (P < 0.05). The TST positivity rate
was highest in children 11-13 years of age (P < 0.05).
Conclusion: The BCG vaccination rate was higher in Kahramanmaraş, whereas the TST positivity rate was lower. The
factors that affected the size of the PPD induration were the number of vaccination scars and the age of the subject.
Key words: Bacillus Calmette-Guerin vaccination, tuberculin skin test, tuberculosis

Kahramanmaraş il merkezinde tüberkülin deri testi pozitifliği prevalansı ve BCG
aşılamasının tüberkülin deri testi endürasyonu üzerine etkisi
Amaç: Bu çalışmanın amacı Kahramanmaraş il merkezinde tüberkülin deri testi (TDT) pozitifliğini değerlendirmek
ve TDT endürasyon büyüklüğünün Bacillus Calmette-Guerin (BCG) skar sayısı ve diğer faktörlere göre değişimini
yorumlamaktır.
Yöntem ve gereç: Çalışmada yaşları 7 ve 17 arasında değişen toplam 2979 okul çocuğu değerlendirildi. Sosyoekonomik
seviyeye göre 11 okul seçildi ve bu okullar gecekondu (grup 1), şehir merkezi (grup 2) ve ilkokullar (grup 3) olarak
alt gruplara ayrıldı. Öğrencilerin BCG skar sayıları kaydedildi ve 5 TU 0,1 ml PPD enjekte edildikten 72 saat sonra
endürasyon büyüklüğünün ölçümü yapıldı.
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Bulgular: BCG’siz öğrencilerde TDT pozitiflik oranı % 6,3, BCG’lilerde ise % 7,5 olarak bulundu (P > 0,05). Çalışmaya
alınan öğrencilerden 174’ünde (% 5,8) BCG skarı yoktu, 1232’sinde (% 41,4) bir adet, 1516’sinde (% 50,9) iki adet,
54’ünde (% 1,8) üç adet, 3’ünde (% 0,1) dört adet BCG skarı mevcut idi. Ortalama TDT endürasyon reaksiyonu aşısız
öğrencilerde 2,50 ± 4,05 mm, tek aşılı öğrencilerde 5,60 ± 5,11 mm, iki aşılılarda 8,49 ± 5,09 mm, üç aşılılarda 8,46 ±
4,38 mm ve dört aşılılarda ise 7,66 ± 6,80 olarak tespit edildi. TDT’nin endürasyon çapı iki BCG aşısı bulunanlarda
belirgin genişti (P < 0,05). TDT pozitifliği 11-13 yaş grubunda daha yüksekti (P < 0,05).
Sonuç: Kahramanmaraş ilinde BCG ile aşılanma oranı ülke genelinden daha yüksekti ve TDT pozitiflik oranları da
oldukça düşüktü. BCG skar sayısı ve yaş TDT endürasyon büyüklüğünü etkileyen faktörlerdi.
Anahtar sözcükler: Bacillus Calmette-Guerin aşılaması, tüberkülin deri testi, tüberküloz

Introduction
Tuberculosis (TB) remains a major health
problem, especially in developing countries. The
World Health Organization (WHO) estimates that 8
million adults and 1.3 million children are diagnosed
with TB annually and 3 million adults and 450,000
children die from TB. Estimating the number of
TB patients and implementing effective treatments
are the major goals of TB eradication programs.
The major role of the Bacillus Calmette-Guerin
(BCG) vaccination is the prevention of serious
and life-threatening diseases such as disseminated
tuberculosis and tubercular meningitis in children
(1-3). The BCG vaccine does not prevent infection
with M. tuberculosis (4). A metaanalysis suggested
that BCG is 50% effective in preventing pulmonary
TB in adults and children, while the protective
effect for disseminated and meningeal TB appears
to be 50%-80% (5). There is no evidence that BCG
prevents infection with Mycobacterium tuberculosis.
Vaccination with BCG is compulsory for all infants
in Turkey. The first vaccine is administered in the
third month and the second vaccine is administered
at the age of 7 years. The Turkish Health Ministry
also recommends BCG vaccination when tuberculin
induration is <5 mm. The WHO recommends a
single dose of BCG vaccine after birth in all countries
with a high incidence of TB infection (2).
The tuberculin skin test (TST) is an important
tool for the detection of TB infection (6). It is
especially significant for detecting TB-infected
pupils in countries with a low incidence of TB where
the BCG vaccine is not regularly used as part of TB
control (7). Although previous vaccination with BCG
in childhood decreases the value of the procedure in
Turkey, the TST is still used for diagnosing childhood
712

TB infection (8). The TST indicates TB infection,
but does not indicate TB disease (9). It is an easy
technique for showing latent infection in pupils that
have had contact with a TB patient and is also ideal
for screening large numbers of people (10). However,
there is no clear indication whether TST positivity is
due to BCG use or atypical mycobacteria. The TST
reaction is directly correlated with the number of
BCG vaccination scars, but it is inversely correlated
with the period of BCG vaccination (11).
In this study, we aimed to evaluate the prevalence
of TST positivity among school children between 7
and 17 years of age and interpret the size of purified
protein derivative (PPD) induration with respect to
the number of BCG scars and other factors.
Materials and methods
The study was conducted among school
children between 7 and 17 years of age in the
city of Kahramanmaraş (located in the eastern
Mediterranean region of Turkey) between November
and December 2006. The sample size of children
was based on an assumed TST positivity rate of 40%
(95% confidence interval). A sample size of 2979
children was sufficient to establish whether TST
positivity was present. Schools were grouped into
3 clusters according to socioeconomic levels, with
categorization as follows: schools in the suburbs of
the city (Group 1), schools in the city center (Group
2), and private schools (Group 3). A random selection
method was used in order to choose 11 schools from
each cluster.
Prior to the beginning of our study, approval was
granted by the Ministry of National Education and
the ethics committee, and signed informed consents
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were obtained from the parents of all children. Parents
were also given a set of questionnaires regarding the
health background and history of their children
and were asked to submit written documents and
statements.
PPD was administered to children by 2 experienced
physicians using the Mantoux method, regardless of
whether the subjects had BCG scars or not. The PPD
solution was injected intradermally into the upper
two-thirds of the volar surface of the left forearm.
Children were injected with 5 TU/0.1 mL of PPDRT23 (Tween-80) and the sizes of the induration
were determined within 72 h of the injection. The
diameter of the PPD induration was measured along
and transverse to the longitudinal axis of the arm 72
h after the injection by a physician using the ballpoint technique and a transparent millimeter-scale
plastic ruler. Those children who had viral infections,
such as varicella, measles, mumps, and influenza,
or who had been given live-virus vaccines within
the last 20 days, were not considered in this study.
Children who had had symptoms after the PPD
injection or the BCG vaccination within the last 6
months were also excluded. In accordance with the
national TB guidelines, a 10-mm cut-off point was
used in children with no BCG scar and a 15-mm
cut-off point was used in children with a BCG scar
(9). Pupils who had a positive TST were referred to
the Kahramanmaraş TB Prevention and Treatment
Center for further TB evaluation.
For all measured parameters, statistical analyses
of between-group differences were performed using
ANOVA, followed by a post hoc Tukey test. The
Pearson correlation coefficient was used to evaluate
the degree of correlation between the parameters.
Proportions were compared using the chi-square
test. P < 0.05 was considered statistically significant
and all analyses were performed using SPSS 11.0 for
Windows (SPSS Inc., Chicago, IL, USA).
Results
Of the 2979 students, 1495 (50.2%) were boys
and 1484 (49.8%) were girls. In terms of regional
distribution, there were 939 (31.5%) students in
Group 1, 1226 (41.2%) in Group 2, and 814 (27.3%)
in Group 3. The mean age of girls and boys was 12.23

± 3.13 and 12.12 ± 3.17 years, respectively. Children
were classified as having no BCG vaccination scars,
1 BCG vaccination scar, 2 BCG vaccination scars, 3
BCG vaccination scars, or 4 BCG vaccination scars.
The number of children having 0, 1, 2, 3, and 4
vaccination scars was 174 (5.8%), 1232 (41.4%), 1516
(50.9%), 54 (1.8%), and 3 (0.1%), respectively. The
BCG scars of children were also compared according
to regions. The percentage of children without
BCG scars was 8.1% in Group 1, 5.4% in Group 2,
and 3.9% in Group 3. The number of BCG scars
was compared with respect to these groups and the
rate of children with no BCG scars in Group 1 was
higher than in Groups 2 and 3 (P < 0.01). The mean
diameter of the PPD induration for Groups 1, 2, and
3 was 6.13 ± 5.23 mm, 7.51 ± 5.42 mm, and 7.03 ±
5.21 mm, respectively (Table 1). The mean diameter
of the PPD induration was found to be significantly
different among the 3 groups using variance analysis
and Tukey’s post hoc test (P < 0.05).
The number of children with TST positivity was
52 (5.5%) in Group 1, 128 (10.4%) in Group 2, and 39
(4.8%) in Group 3. In comparing TST positivity with
respect to regions, the rate was significantly higher in
Group 2 (P < 0.001).
Overall TST positivity was found in 219 (7.4%)
children and, when compared with respect to gender,
the rate was 7.8% in boys and 6.8% in girls (P > 0.05).
The TST was positive in 208 (7.5%) children with
at least 1 BCG scar, while the TST was positive in 11
(6.3%) of 174 children who had no BCG scars (P >
0.05). When comparing TST positivity with respect
to the number of BCG scars, the TST positivity rate
was higher in children with 2 scars (P < 0.001).
The number of BCG vaccination scars was 0 in
174 children (5.8%), 1 in 1232 children (41.4%), 2
in 1516 children (50.9%), 3 in 54 children (1.8%),
and 4 in 3 children (0.1%) The mean diameter of
the size of the PPD induration for 0, 1, 2, 3, and 4
BCG vaccinations was 2.50 ± 4.05 mm, 5.60 ± 5.11
mm, 8.49 ± 5.09 mm, 8.46 ± 4.38 mm, and 7.66 ±
6.80 mm, respectively. The size of the induration was
greatest in pupils that had been vaccinated twice (P
< 0.05; Figure 1). The mean diameter of the PPD
induration in children with 1, 2, or more BCG scars
was significantly different using variance analysis
and post hoc testing (P < 0.001). Information on the
713
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Table 1. Mean diameters of PPD induration according to regional groups and number of scars.
Regional group

Number of scars

Number of persons (n)

Mean diameter of PPD (mm)

0 BCG

76

1.56 ± 3.42 mm

1 BCG

400

5.15 ± 5.13 mm

2 BCG

447

7.79 ± 4.92 mm

3 BCG + 4 BCG

16

6.00 ± 4.25 mm

0 BCG

66

3.18 ± 4.43 mm

1 BCG

489

6.25 ± 5.31 mm

2 BCG

651

8.85 ± 5.16 mm

3 BCG

20

8.75 ± 4.98 mm

0 BCG

32

3.31 ± 4.27 mm

1 BCG

343

5.18 ± 4.70 mm

2 BCG

418

8.69 ± 5.096 mm

3 BCG + 4 BCG

21

9.95 ± 3.35 mm

Group 1

Group 2

Means of induration size (mm)

Group 3

9
8
7
6
5
4
3
2
1
0

0 BCG

1 BCG

2 BCG
3 BCG
Number of scars

4 BCG

Figure 1. Mean diameters of indurations with regard to the
number of scars.

determined to be 5.62 ± 5.05 mm for the group
7-10 years of age, 8.32 ± 5.33 mm for the group 1113 years of age, and 7.11 ± 5.31 mm for the group
14-17 years of age. The mean PPD diameter was
shown to be significantly different between the 3
groups using variance analysis (P < 0.001; Figure 2).
A positive correlation was detected between age and
TST positivity (P < 0.001). After being identified as
TST-positive, one child was diagnosed with TB and
antituberculosis treatment was initiated.
12.0%

Children were further classified into the following
3 age groups: 7-10 years of age, 11-13 years of age,
and 14-17 years of age. The mean size of the PPD
induration was measured for each group and was
714

10.0%
8.0%
Positivity

number of scars and the size of the PPD induration
was evaluated by correlation analysis; a moderate
correlation existed (r = 0.324, P < 0.001). The mean
PPD induration diameter was 16.51 ± 2.46 mm in
260 children who were TST-positive.

6.0%
4.0%
2.0%
0.0%

7

8

9

10

11

12 13
Age

14

15

16

17

Figure 2. Distribution of TST-positive children in terms of age.
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Discussion
Treatment and vaccination programs, population
screening, and diagnosis of TB in childhood are
very important tools for public health studies (3).
TST is a valuable test used to predict the incidence
of TB; however, there is no clear indication whether
increased PPD values in children are due to BCG
vaccination or TB infection (12,13). It is also not
clear how many millimeters of induration should
be considered positive. Repeated BCG vaccinations,
age, PPD solution content, repeated doses of vaccine,
personal nutrition, and immunologic status may
confound the interpretations of the TST (9). In
Turkey, it is difficult to interpret PPD indurations in
different groups and this remains a subject for further
research.
In Turkey, no standard approaches exist for
managing TST positivity. The TST is generally
considered positive if the induration size is >10 mm
in children having a BCG scar; in some studies,
however, an induration size >15 mm is considered
positive (14). Şakar et al. (13) found a TST positivity
rate of 21.2% in school children between the ages of
7 and 18 years in Manisa. The PPD was considered
positive if the induration size was >10 mm. Other
studies that considered PPD-positive results to be
>6 mm in pupils with no BCG scar and >10 mm in

pupils with a recent BCG scar reported TST positivity
rates of 4.1%-9.1% and 43.2%-56.2%, respectively
(15,16). Another study that used a 10-mm cut-off
point reported TST positivity rates of 1.5%-13.5% in
pupils with no BCG scar and 20.2%-67% in pupils
with a BCG scar (14). Most of these studies included
first- and fifth-grade elementary school students (1518). The TST positivity rates in Turkey are shown in
Table 2.
In the current study, a 10-mm cut-off point was
used in children with no BCG scar and a 15-mm
cut-off point was used in children with a BCG scar,
in accordance with the national TB guidelines. TST
positivity was found in 6.3% of children with no BCG
scar, 7.5% of children with at least 1 BCG scar, and
7.4% of the general population of the study. The TST
positivity rate was lower than that reported in other
studies (12-28,29). This may be a result of using a 15mm cut-off point for a positive TST.
TST positivity rates show variation based on
the regions studied. Kolsuz et al. (14) reported
a TST positivity rate of 2% in a region of low
socioeconomic and cultural development in the
city of Eskişehir. In a study that Uzun et al. (22)
conducted with children who migrated to the city
center from villages, the rate of children having
no BCG scar was reported as 66% and the TST

Table 2. Prevalence of TST positivity in different studies.
Number
of persons
included

Region

Age
group

TST
Positivity

Cut-off point of PPD

Akkaya et al. 1994 (12)

2133

Isparta

0-15 and >15

63%

≥10 mm

Uzun et al. 1998 (22)

377

Van

0-17

48%

≥10 mm

69.3%

≥10 mm

Study

Uçan et al. 1998-1999 (21)

2835

İzmir, Nazilli, Artvin

6-82

Kolsuz et al. 2000 (14)

2417

Eskişehir

7

6.5%

BCG(–): >10 mm BCG(+): >15 mm

Şakar et al. 2001 (13)

438

Manisa

7-18

21.2%

≥10 mm

Çakıcı et al. 2003 (23)

1491

Çanakkale

7

4.4%

BCG(–): >10 mm BCG(+): >15 mm

Our study 2006

2979

Kahramanmaraş

7-17

7.4%

BCG(–): >10 mm BCG(+): >15 mm
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positivity rate was found to be 3.9% among the
nonvaccinated children. A major reason for the low
TST positivity rate cited in that study may be related
to the children’s isolated lifestyles. In our study, TST
positivity was 5.5% in Group 1, 10.4% in Group
2, and 4.8% in Group 3. The results demonstrate
that BCG vaccination is insufficient in rural areas;
however, a low TST positivity rate in these areas
indicates that natural infection does not increase
in poor living conditions. In our study, Group 1
consisted of children from different villages who
went to a regional elementary boarding school.
The low TST rate in this group may be due to the
isolated lifestyle of the families of the children (22).
BCG vaccinations are compulsory for all infants
in Turkey. The Ministry of Health recommends the
first vaccine in the second month and the second at
7 years of age (9,24). Vaccination programs in the
country seem inefficient, however, because studies
have detected children at 7 years of age with no BCG
scar. The BCG scar rate of 7-year-old school children
in different regions of Turkey shows variations due to
different socioeconomic conditions (13,14,22,24). The
rate of BCG scars among migrants was 26.3% in Van
(a city in eastern Turkey) while it was 99.5% in Manisa
(a city in the Aegean region of Turkey) (13,22). Table
3 summarizes the rates found in different studies in
Turkey. In the current study, the rate of children with
a BCG scar was found to be 94.2%, suggesting that

Kahramanmaraş (a city in the Mediterranean region)
is a city of efficient vaccination.
There are studies suggesting that the size of the
PPD induration may increase significantly with
the number of BCG scars (13,14,25). In studies
performed by Uçan et al. and Ildirim et al., PPD
diameters increased and reactions had a high
correlation with the increasing number of BCG scars
(21,30). Gundogdu et al. (29) showed an increase in
the diameter of the PPD induration with the number
of BCG scars in a study conducted on 1879 school
children between 7 and 14 years of age in Kocaeli.
In our study, it was found that the presence of 1 or 2
BCG scars induced higher tuberculin reactivity than
did the presence of no scars (Figure 2).
In the United States, the prevalence of TST
positivity among children newly enrolled in primary
school was 1%-2%, a figure that increased to 10%
in those entering secondary school. The factors
associated with TST positivity were age, BCG
coverage, and birth outside of the US (31-33). Studies
show that overall TST positivity is lower in Turkey
than in the USA. High TST positivity rates in parts of
Turkey may be explained by routine BCG vaccination
and low socioeconomic conditions.
BCG vaccination is considered an important
protective measure with regards to TB disease and
there are studies discussing its protection capability;

Table 3. BCG scar rates in Turkish studies.
Study

Place

Year

Age group

BCG scar positivity

Eskişehir

1987

7-11

84.4%

Uzun et al. (22)

Van

1998

0-17

66%

Kolsuz et al. (14)

Eskişehir

2000

7

89.9%

Şakar et al. (13)

Manisa

2001

7-18

99.5%

Çakıcı et al. (23)

Çanakkale

2003

7

88.6%

Özşahin et al. (27)

Sivas

2003

7

83.1%

Bozkanat et al. (28)

İstanbul

2003

18-21

92.7%

Tanrıkulu et al. (26)

Şırnak

2005

7

25.3%

Kahramanmaraş

2006

7-17

94.2%

Özdemir et al. (18)

Our study
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however, repeated vaccination after the first vaccine
is not recommended as a way of increasing its
effectiveness (26,34-36). The mean size of the PPD
induration of the study group was 6.9 ± 5.3 mm, 6.9
± 5.2 mm for girls and 6.9 ± 5.4 mm for boys. TST
positivity was found in 6.8% of girls and 7.8% of boys.
There were no significant differences determined
between boys and girls, which may be due to the fact
that our study consisted of a childhood population.
Children were classified into 1 of the 3 following
age groups: 7-10 years of age, 11-13 years of age, and
14-17 years of age. The mean size of PPD induration
was measured for each group; it was 5.62 ± 5.05 mm
for the group 7-10 years of age, 8.32 ± 5.33 mm for
the group 11-13 years of age, and 7.11 ± 5.31 mm
for the group 14-17 years of age. The main factor
for the lower PPD size in the third group may be the
decreasing effect of BCG with time.

In our study, TST positivity increased and had a
positive correlation with age. The results from other
studies performed in Turkey are also concordant with
the claim made in our study that PPD reaction has
a correlation with age (13-21). This may be related
to the increase in the number of BCG scars and the
increase in the risk of TB infection due to exposure
after childhood.
Due to the high number of participants in our
study, we were not able to study the booster effect;
this shortcoming represents the weakness of the
present research.
In conclusion, the BCG vaccination rate in
Kahramanmaraş was high, with an overall rate of
94.2%, and TST positivity was low, with a rate of
7.4%. The number of vaccinations (up to 3 scars) and
age of the study subjects were the factors that affected
the size of PPD induration.
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